Associations of Plasma Concentration Profiles of Dapagliflozin, a Selective Inhibitor of Sodium–Glucose Co-Transporter Type 2, with Its Effects in Japanese Patients with Type 2 Diabetes Mellitus

Associations of Plasma Concentration Profiles of Dapagliflozin, a Selective Inhibitor of Sodium–Glucose Co-Transporter Type 2, with Its Effects in Japanese Patients with Type 2 Diabetes Mellitus

This study was conducted to evaluate the long-term plasma concentration profiles of dapagliflozin and its effects on the glycated hemoglobin (HbA1c) level, body weight, and estimated glomerular filtration rate (eGFR) in 72 Japanese outpatients with type 2 diabetes mellitus (T2DM) receiving metformin...

Full description

Bibliographic Details
Main Authors: Tetsuo Hayakawa, Ken-Ichiro Kato, Shinji Kobuchi, Kaede Kataoka, Toshiyuki Sakaeda
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Pharmaceuticals
Subjects:
type 2 diabetes mellitus
dapagliflozin
plasma concentration
adherence
HbA1c
body weight
Online Access:https://www.mdpi.com/1424-8247/15/2/203

Internet

https://www.mdpi.com/1424-8247/15/2/203

Similar Items